These data suggest that increased plasma Fgf21 under fasting could promote improved lipid homeostasis while the depletion of hepatic Fgf21 (and thus reducing plasma Fgf21 levels) per se might not instigate metabolic disorders. Here, FGF21 is linked to metabolic disease.